Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective
Non-small cell lung cancer is a prevalent and rapidly-expanding challenge to modern medicine. While generalized medicine with traditional chemotherapy yielded comparatively poor response rates and treatment results, the cornerstone of personalized medicine using genetic profiling to direct treatment...
Saved in:
Main Authors: | Wenxiao Jiang (Author), Guiqing Cai (Author), Peter C. Hu (Author), Yue Wang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer
by: Wenxiao Jiang, et al.
Published: (2021) -
KRAS and the Reality of Personalized Medicine in Non-Small Cell Lung Cancer
by: Havva O Kilgoz, et al.
Published: (2016) -
Personalized medicine and treatment approaches in non-small-cell lung carcinoma
by: Vadakara J, et al.
Published: (2012) -
Pharmacogenomics and Personalized Medicine
Published: (2020) -
Personalized medicine in breast cancer: pharmacogenomics approaches
by: Jeibouei S, et al.
Published: (2019)